Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

Cure Rare Disease (CRD) announced it has been awarded a $5.69 million grant from the California Institute for Regenerative Medicine (CIRM) to advance the development of an antisense oligonucleotide ...

Recovery.com, a global platform that connects patients, loved ones, and providers to mental health and addiction treatment options, has released its first-ever State of Recovery report. Based on ...

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going ...

Drug Information and Alerts Aotearoa New Zealand (DIANZ) warns about vapes containing dangerous ‘space oil’. Etomidate vapes ...

Franke James, QUOI MediaYou degenerate, you!I am a rebel, but I have never considered myself a "degenerate." Yet, this word ...

Cantor Fitzgerald's analysts demonstrated a positive outlook on PTC Therapeutics (NASDAQ:PTCT), increasing the price target to $113.00 from the previous $76.00. The firm maintains an Overweight rating ...

Governor Kathy Hochul announced this week the temporary closure of all live bird markets in several downstate counties after seven different markets found positive cases of bird flu, which has been ...

CHARLESTOWN, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SLDB) (the “Company”), a life sciences company developing ...

After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.